alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 217
Editorial Note: Nomenclature changes to part 217 appear at 68 FR 51362, Aug. 26, 2003.

§ 217.7 Designation of responsible employee and adoption of grievance procedures. ( a ) *Designation of responsible employee.* A recipient that employs fifteen or more persons shall designate at least one person to coordinate its efforts to comply with this part.
( b ) *Adoption of grievance procedures.* A recipient that employs fifteen or more persons shall adopt grievance procedures that incorporate appropriate due process standards and that provide for the prompt and equitable resolution of complaints alleging any action prohibited by this part. Such procedures need not be established with respect to complaints from applicants for employment or from applicants for admission to postsecondary educational institutions.
U.S. DEPARTMENT OF THE INTERIO

R

U.S. GEOLOGICAL SURVEY
### §285c–7. Biennial report

The Director of the Institute shall prepare for inclusion in the biennial report made under section 284b 1 of this title a description of the Institute's activities—

(1) under the current diabetes plan under the National Diabetes Mellitus Research and Education Act; and

(2) under the current digestive diseases plan formulated under the Arthritis, Diabetes, and Digestive Diseases Amendments of 1976.

The description submitted by the Director shall include an evaluation of the activities of the centers supported under section 285c–5 of this title.

(July 1, 1944, ch. 373, title IV, §433, as added Pub. L. 99–158, §2, Nov. 20, 1985, 99 Stat. 848.)

#### **Editorial Notes**

#### References in Text

Section 284b of this title, referred to in text, was repealed by Pub. L. 109–482, title I, §104(b)(1)(C), Jan. 15, 2007, 120 Stat. 3693.

The National Diabetes Mellitus Research and Education Act, referred to in par. (1), is Pub. L. 93–354, July 23, 1974, 88 Stat. 373, which enacted former sections 289c–1a, 289c–2, and 289c–3 of this title, amended section 247b and former section 289c–1 of this title, and enacted provisions formerly set out as notes under section 289c–2 of this title. For complete classification of this Act to the Code, see Short Title of 1974 Amendments note set out under section 201 of this title and Tables.

The Arthritis, Diabetes, and Digestive Diseases Amendments of 1976, referred to in par. (2), is Pub. L. 94–562, Oct. 19, 1976, 90 Stat. 2645, which enacted former sections 289c–3a, 289c–7, and 289c–8 of this title, amended former sections 289c–2, 289c–5, and 289c–6 of this title, and enacted provisions formerly set out as notes under sections 289a, 289c–3a, and 289c–7 of this title. For complete classification of this Act to the Code, see Short Title of 1976 Amendments note set out under section 201 of this title and Tables.

1 See References in Text note below.
#### The People of the State of New York, Respondent, v Gail Bosted Callahan, Appellant.

Appeal by defendant from a judgment of the County Court, Nassau County, rendered April 2, 1976, convicting her of criminal sale of a controlled substance in the third degree, upon a jury verdict, and imposing sentence. Judgment reversed, as a matter of discretion in the interest of justice, and new trial ordered. The trial court erred in charging the jury as follows: "There are certain criteria that you may consider in determining whether the defendant was actually acting solely as an agent of the buyer. You may consider whether the defendant was associated with the seller in selling drugs, whether she was acting in concert with the seller, or was the seller’s accomplice, or whether the defendant expected to receive or did receive financial or personal gain. If you find any of these facts then the defendant cannot be deemed to be an agent of the buyer.” Under the facts of this case, the jury would have been justified in finding that the defendant acted solely as the buyer’s agent, even though she may have expected to personally gain from the drug transaction. However, the trial court, by the portion of the charge quoted above, improperly removed this option from the jury (see *People v Brown,*60 AD2d 917; *People v Bostick,*51 AD2d 749). In view of the degree of prejudice attendant upon this error, a new trial is warranted in the interest of justice, notwithstanding defense counsel’s failure to take timely objection to the *1016improper charge (see CPL 470.15, subd 6, par [a]). Hopkins, J. P., Latham, Damiani and Titone, JJ., concur.
**
Exhibit 8.1 

 

**Business Name**
  **Jurisdiction of Incorporation**
4Front Holdings LLC
  Arizona
4Front Advisors, LLC
  Various
Mission Partners USA, LLC
  Arizona
Linchpin Investors, LLC
  Arizona
Healthy Pharms, Inc.
  Massachusetts
4Front Management Associates, LLC
  Massachusetts
MMA Capital, LLC
  Massachusetts
Illinois Grown Medicine, LLC
  Illinois
Harborside Illinois Grown Medicine Inc.
  Illinois
Mission Maryland, LLC
  Maryland
4Front CIHI Investco, LLC
  Maryland
4Front PM Investco, LLC
  Maryland
4Front MARI Investco, LLC
  Maryland
Silver Spring Consulting Group, LLC
  Maryland
Adroit Consulting Group, LLC
  Maryland
Old Line State Consulting Group, LLC
  Maryland
Om of Medicine LLC
  Michigan
Mission MA Inc.
  Massachusetts
4Front Arkansas LLC
  Arkansas
Arkansas Natural Products I *Management LLC
  Arkansas
Pine Bluff Agriceuticals I Management LLC
  Arkansas
Real Estate Properties LLC
  Washington
Fuller Hill Development LLC
  Washington
Ag-Grow Imports LLC
  Washington
Brightleaf Development LLC
  Washington
Cannex Holdings (Nevada) Inc.
  Washington
Cannex Holdings (California) Inc.
  Washington**
[Federal Register Volume 69, Number 241 (Thursday, December 16, 2004)]
[Notices]
[Pages 75344-75345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-27538]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Alliance for Telecommunications Industry 
Solutions

    Notice is hereby given that, on September 20, 2004, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Alliance for 
Telecommunications Industry Solutions (``ATIS'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing (1) the name and principal place of

[[Page 75345]]

business of the standards development organization and (2) the nature 
and scope of its standards development activities. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: Alliance for 
Telecommunications Industry Solutions, Washington, DC. The nature and 
scope of ARIS' standards development activities are: To develop and 
promote technical and operations standards for the communications and 
related information technologies industry worldwide using a pragmatic, 
flexible and open approach.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 04-27538 Filed 12-15-04; 8:45 am]
BILLING CODE 4410-11-M
#### § 1508.355 What information must I provide to a higher tier participant before entering into a covered transaction with that participant?

Before you enter into a covered transaction with a person at the next higher tier, you as a lower tier participant must notify that person if you know that you or any of the principals are presently excluded or disqualified.
I 

112TH CONGRESS 

2D SESSION H. R. 4283 

To amend the Child Care and Development Block Grant Act of 1990 to 

require child care providers to provide to parents information regarding 

whether such providers carry current liability insurance. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 28, 2012 

Mr. BARROW introduced the following bill; which was referred to the 

Committee on Education and the Workforce 

A BILL 

To amend the Child Care and Development Block Grant 

Act of 1990 to require child care providers to provide 

to parents information regarding whether such providers 

carry current liability insurance. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Anthony DeJuan 

5 Boatwright Act’’. 


pwalker on DSK7TPTVN1PROD with BILLS
2 

•HR 4283 IH

1 SEC. 2. AMENDMENTS. 

2 Section 658e(c)(2) of the Child Care and Develop3 ment Block Grant Act of 1990 (42 U.S.C. 9858c(c)(2)) 

4 is amended— 

5 (1) in subparagraph (E)(i) by adding at the end 

6 the following: ‘‘The State shall include as part of its 

7 regulatory process for issuance and renewal of li8 censes to providers of child care services, a rec9 ommendation to each provider that it carry current 

10 liability insurance covering the operation of its child 

11 care business.’’, and 

12 (2) in subparagraph (F)— 

13 (A) in clause (ii) by striking ‘‘and’’ at the 

14 end, 

15 (B) in clause (iii) by striking the period at 

16 the end and inserting a semicolon, 

17 (C) by inserting after clause (iii) the fol18 lowing: 

19 ‘‘(iv) a requirement that each licensed 

20 child care provider— 

21 ‘‘(I) post publicly and conspicu22 ously in the service area of its prem23 ises a notice specifying whether or not 

24 such provider carries current liability 

25 insurance covering the operation of its 

26 child care business; 


pwalker on DSK7TPTVN1PROD with BILLS
3 

•HR 4283 IH

1 ‘‘(II) provide to parents of chil2 dren to whom it provides child care 

3 services a written notice stating 

4 whether or not such provider carries 

5 current liability insurance covering the 

6 operation of its child care business, 

7 including the amount of any such cov8 erage; 

9 ‘‘(III) obtain the signature of at 

10 least 1 parent of each such child on 

11 such written notice acknowledging 

12 that such parent has received such no13 tice; and 

14 ‘‘(IV) maintain such notice (or a 

15 copy of such notice) as signed by such 

16 parents (or a copy of the signed no17 tice) in such provider’s records during 

18 the period in which the child receives 

19 such services.’’, and 

20 (D) in the last sentence by inserting 

21 ‘‘clauses (i), (ii), or (iii) of’’ after ‘‘Nothing in’’. 

22 SEC. 3. EFFECTIVE DATE. 

23 This Act and the amendments made by this Act shall 

24 take effect on October 1 of the 1st fiscal year that begins 


pwalker on DSK7TPTVN1PROD with BILLS
4 

•HR 4283 IH

1 more than 1 year after the date of the enactment of this 

2 Act. 

Æ 


pwalker on DSK7TPTVN1PROD with BILLS
**
**Exhibit 31.1**

**Certification of Chief Executive Officer Pursuant to**

**Section 302 of the Sarbanes-Oxley Act of 2002**

I, Joseph Coccaro, certify that: 

 
1.
I have reviewed this Annual Report on Form 10-K/A of Bogota FinancialCorp.; 

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in ExchangeAct Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 
 a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to bedesigned under my supervision, to ensure that material information relating to the registrant is made known to me by others within the entity, particularly during the period in which this report is being prepared; 

 
 b)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 
 c)
Disclosed in this report any change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 
5.
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board of directors: 

 
 a)
All significant deficiencies and material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 
 b)
Any fraud, whether or not material, that involves management or other employees who have a significant role inthe registrant’s internal control over financial reporting. 

 
  Date: April 29, 2020   
/s/ Joseph Coccaro
   Joseph Coccaro   President and Chief Executive Officer**
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title:****Ground-water levels in theUnited States. Northeastern states.**
 
1956-57 | 1958-62 | 1963-67 | 1968-72 | 1973-74
 
SuDoc Number:I 19.13:
Item Number:0625 (online)
CGP systemNumber:001104685
 
August 22, 2019
§ 1006.935 Debarring official. ( a ) *Debarring official* means an agency official who is authorized to impose debarment. A debarring official is either— ( 1 ) The agency head; or
( 2 ) An official designated by the agency head.
( b ) [Reserved]
| **Claim and Claim Adjustment Expense Reserves (Narrative) (Details) (USD $)In Millions, unless otherwise specified** | 3 Months Ended |
|----------------------------------------------------------------------------------------------------------------------|----------------|
||
| Catastrophe losses net of reinsurance                                                                                | $ 39           | $ 28 |

| X                                                                                                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Catastrophe losses net of reinsurance
+ References
No definition available.
+ Details**Name:**cna_CatastropheLossesNetOfReinsurance**Namespace Prefix:**cna_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
<PAGE>1

                        Exhibit 21.1
                        SUBSIDIARIES
               THE SABRE GROUP HOLDINGS, INC.



THE SABRE GROUP HOLDINGS, INC. SUBSIDIARIES
 (EACH SUBSIDIARY'S SUBSIDIARIES OUTLINED FURTHER BELOW)*

   The SABRE Group, Inc.  (Delaware)

THE SABRE GROUP, INC. SUBSIDIARIES
   
   Axess International Network, Inc. (Japan) (25%)
   ENCOMPASS Holding, Inc. (Delaware)
   Prize Ltd. (Latvia) (50%)
   SABRE Decision Technologies International, Inc. (Delaware)
   SABRE Decision Technologies Licensing, Inc. (Delaware)
   SABRE International Holdings, Inc. (Delaware)
   SABRE International, Inc. (Delaware)
   SST Finance, Inc. (Delaware)
   SST Holding, Inc. (Delaware)
   TSGL, Inc. (Delaware)
   Ticketnet Corporation (Canada)
   SABRE Enterprises, Inc. (Delaware)
   The SABRE Group Sales (Barbados), Ltd.

ENCOMPASS HOLDING, INC. SUBSIDIARY*

   ENCOMPASS (partnership) (50%)

SABRE DECISION TECHNOLOGIES INTERNATIONAL, INC. SUBSIDIARY*

   SABRE Decision Technologies (Australia) Pty Ltd.

SABRE INTERNATIONAL, INC. SUBSIDIARIES*

   SABRE Belgium (Belgium) (99%)
   SABRE Computer-Reservierungssystem GmbH (Austria)
   SABRE Danmark ApS (Denmark)
   SABRE Deutschland Marketing GmbH (Germany)
   SABRE Deutschland Services GmbH (Germany)
   SABRE Espana Marketing, S.A. (Spain) (99%)
   SABRE Europe Management Services Ltd. (UK) (99%)
   SABRE France Sarl (France)
   SABRE Hellas SA (Greece)
   SABRE Ireland Limited (Ireland)

<PAGE> 2

SABRE INTERNATIONAL, INC. SUBSIDIARIES* - CONTINUED

   SABRE Italia S.r.l. (Italy) (99%)
   SABRE Marketing Nederland B.V. (The Netherlands)
   SABRE Norge AS (Norway)
   SABRE Portugal Servicos Lda (Portugal) (99%)
   SABRE Suomi Oy (Finland)
   SABRE Sverige AB (Sweden)
   SABRE UK Marketing Ltd. (UK) (99%)
   STIN Luxembourg S.A. (Luxembourg) (99%)

SABRE INTERNATIONAL HOLDINGS, INC. SUBSIDIARIES*

   SABRE Belgium (Belgium) (1%)
   SABRE Espana Marketing, S.A. (Spain) (1%)
   SABRE Europe Management Services Ltd. (UK) (1%)
   SABRE Italia S.r.l. (Italy) (1%)
   SABRE Portugal Servicos LDA (Portugal) (1%)
   SABRE Servicios Colombia LTDA (Columbia) (1%)
   SABRE UK Marketing Ltd. (UK) (1%)
   STIN Luxembourg SA (Luxembourg) (1%)
         
SST HOLDING, INC. SUBSIDIARY*

   SABRE Sociedad Technolgica S.A. (Mexico) (50%)
   
SABRE SOCIEDAD TECHNOLOGICA S.A. SUBSIDIARY*
   
   SABRE Services Administration (Mexico)

TSGL, INC. SUBSIDIARIES*

   TSGL Holding, Inc. (Deleware)
   TSGL-SCS, Inc. (Deleware)

TICKETNET CORPORATION SUBSIDIARY*

   148548 Canada, Inc. (Canada)


* All subsidiaries are wholly-owned unless otherwise noted in parenthesis
Exhibit 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO

                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report on Form 10-QSB of Mooney Aerospace
Group, Ltd. (the "Company") for the period ended June 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Barry
Hodkin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to the best of my knowledge:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.


Dated:  August 21, 2006              By: /s/ Barry Hodkin
                                         ---------------------------------------
                                         Barry Hodkin
                                         Chief Financial Officer
Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 08-51078

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

RAUL HERRERA-PINA,

Defendant-Appellant

Appeal from the United States District Court

for the Western District of Texas

USDC No. 3:08-CR-1907-ALL

Before JONES, Chief Judge, and JOLLY and ELROD, Circuit Judges.

PER CURIAM:*

Appealing the judgment in a criminal case, Raul Herrera-Pina

raises arguments that are foreclosed by Almendarez-Torres v. United States,

523 U.S. 224, 235 (1998), which held that 8 U.S.C. § 1326(b)(2) is a penalty

provision and not a separate criminal offense. United States v. PinedaArrellano, 492 F.3d 624, 625 (5th Cir. 2007), cert. denied, 128 S. Ct. 872 (2008).

The Government’s motion for summary affirmance is GRANTED, and the

judgment of the district court is AFFIRMED.

United States Court of Appeals

Fifth Circuit

F I L E D

April 30, 2009

Charles R. Fulbruge III

Clerk
PUBLIC LAW 115–181—JUNE 5, 2018 132 STAT. 1391 

Public Law 115–181 

115th Congress 

An Act 

To redesignate certain clinics of the Department of Veterans Affairs located in 

Montana. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. REDESIGNATION OF CERTAIN DEPARTMENT OF VETERANS 

AFFAIRS CLINICS IN MONTANA. 

(a) DAVID J. THATCHER VA CLINIC.— 

(1) DESIGNATION.—The clinic of the Department of Veterans 

Affairs located at 2687 Palmer Street in Missoula, Montana, 

shall after the date of the enactment of this Act be known 

and designated as the ‘‘David J. Thatcher VA Clinic’’. 

(2) REFERENCES.—Any reference in any law, regulation, 

map, document, paper, or other record of the United States 

to the clinic referred to in paragraph (1) shall be considered 

to be a reference to the David J. Thatcher VA Clinic. 

(b) DR. JOSEPH MEDICINE CROW VA CLINIC.— 

(1) DESIGNATION.—The clinic of the Department of Veterans 

Affairs located at 1775 Spring Creek Lane in Billings, Montana, 

shall after the date of the enactment of this Act be known 

and designated as the ‘‘Dr. Joseph Medicine Crow VA Clinic’’. 

(2) REFERENCES.—Any reference in any law, regulation, 

map, document, paper, or other record of the United States 

to the clinic referred to in paragraph (1) shall be considered 

to be a reference to the Dr. Joseph Medicine Crow VA Clinic. 

(3) PUBLIC DISPLAY OF NAME.— 

(A) IN GENERAL.—Any local public display of the name 

of the clinic referred to in paragraph (1) carried out by 

the United States or through the use of Federal funds 

shall include the English name, Dr. Joseph Medicine Crow, 

and the Crow name, Dakaak Baako, of Dr. Joseph Medicine 

Crow. 

(B) LOCAL DISPLAY.—For purposes of subparagraph (A), 

a local public display of the name of the clinic referred 

to in paragraph (1) includes a display inside the clinic, 

on the campus of the clinic, and in the community surrounding the clinic, such as signs directing individuals 

to the clinic. 

(c) BENJAMIN CHARLES STEELE VA CLINIC.— 

(1) DESIGNATION.—The clinic of the Department of Veterans 

Affairs located at 1766 Majestic Lane in Billings, Montana, 

shall after the date of the enactment of this Act be known 

and designated as the ‘‘Benjamin Charles Steele VA Clinic’’. 

June 5, 2018 

[S. 1282] 

132 STAT. 1392 PUBLIC LAW 115–181—JUNE 5, 2018 

LEGISLATIVE HISTORY—S. 1282: 

CONGRESSIONAL RECORD: 

Vol. 163 (2017): Aug. 2, considered and passed Senate. 

Vol. 164 (2018): May 21, considered and passed House. 

Æ 

(2) REFERENCES.—Any reference in any law, regulation, 

map, document, paper, or other record of the United States 

to the clinic referred to in paragraph (1) shall be considered 

to be a reference to the Benjamin Charles Steele VA Clinic. 

Approved June 5, 2018.
### §300e–15. Repealed. Pub. L. 97–35, title IX, §949(b), Aug. 13, 1981, 95 Stat. 578

Section, act July 1, 1944, ch. 373, title XIII, §1316, as added Oct. 8, 1976, Pub. L. 94–460, title I, §116, 90 Stat. 1954, related to administration of programs.